The MMR VUS detected in 9 CRC patients were distributed as follows: three in MLH1, two in MSH2 and PMS2, respectively, and only one in MSH6 and EPCAM, respectively (Figure 2 and Table 3). This evidence concerns the gene PMS2 and colorectal carcinoma.